EVOK Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 16:00):

Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases...

Stats
Today's Volume	15 641.00
Average Volume	40 874.00
Market Cap	3.70M
EPS	$-0.590 ( 2024-03-14 )
Next earnings date	( $-0.210 ) 2024-05-13
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.190
ATR14	$0.0130 (2.98%)

Insider Trading

Date	Person	Action	Amount	type
2023-05-10	Widder Kenneth J	Buy	14 250	Stock Option (Right to Buy)
2023-05-10	Reed Vickie S	Buy	15 000	Stock Option (Right to Buy)
2023-05-10	Hill Malcolm R	Buy	14 625	Stock Option (Right to Buy)
2023-05-10	Garner Cam L	Buy	17 750	Stock Option (Right to Buy)
2023-05-10	Brady Todd C	Buy	14 625	Stock Option (Right to Buy)

INSIDER POWER
100.00
Last 99 transactions
Buy: 6 847 814 \| Sell: 1 253 905

Evoke Pharma Inc Correlation

10 Most Positive Correlations
BGNE	0.878
BNIXU	0.865
FEM	0.853
IMAB	0.852
BLZE	0.847
CLDX	0.845
VRDN	0.843
DADA	0.833
EFAS	0.831
COLL	0.827

10 Most Negative Correlations
RMRM	-0.957
PMD	-0.885
GAINL	-0.869
XPER	-0.858
NEXI	-0.853
RIBT	-0.851
SNCR	-0.85
LEDS	-0.845
TCRX	-0.845
FIZZ	-0.836

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Evoke Pharma Inc Financials

Annual	2023
Revenue:	$5.18M
Gross Profit:	$4.98M (96.10 %)
EPS:	$-2.33

Q4	2023
Revenue:	$1.68M
Gross Profit:	$1.62M (96.48 %)
EPS:	$-0.590

Q3	2023
Revenue:	$1.56M
Gross Profit:	$1.53M (97.77 %)
EPS:	$-0.510

Q2	2023
Revenue:	$1.13M
Gross Profit:	$1.07M (94.93 %)
EPS:	$-0.560

Financial Reports:

No articles found.

Evoke Pharma Inc

Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase 3 clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.